Novozymes A/S

  • Market Cap: N/A
  • Industry: Specialty Chemicals
  • ISIN: DK0060336014
DKK
400.60
-7.9 (-1.93%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

784.28 k

Shareholding (Dec 2023)

FII

0.06%

Held by 8 FIIs

DII

99.94%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

DKK 169,843 Million ()

stock-summary
P/E

37.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.14

stock-summary
Return on Equity

5.66%

stock-summary
Price to Book

2.12

Revenue and Profits:
Net Sales:
7,600 Million
(Quarterly Results - Jun 2025)
Net Profit:
1,021 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.53%
0%
-9.53%
6 Months
-2.98%
0%
-2.98%
1 Year
-9.45%
0%
-9.45%
2 Years
30.53%
0%
30.53%
3 Years
1.83%
0%
1.83%
4 Years
-15.13%
0%
-15.13%
5 Years
2.46%
0%
2.46%

Novozymes A/S for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
11.53%
EBIT Growth (5y)
10.18%
EBIT to Interest (avg)
57.48
Debt to EBITDA (avg)
0.87
Net Debt to Equity (avg)
0.13
Sales to Capital Employed (avg)
0.18
Tax Ratio
22.65%
Dividend Payout Ratio
124.39%
Pledged Shares
0
Institutional Holding
0.10%
ROCE (avg)
23.30%
ROE (avg)
26.58%
Valuation key factors
Factor
Value
P/E Ratio
37
Industry P/E
Price to Book Value
2.12
EV to EBIT
32.15
EV to EBITDA
22.04
EV to Capital Employed
1.88
EV to Sales
7.77
PEG Ratio
NA
Dividend Yield
0.00%
ROCE (Latest)
5.84%
ROE (Latest)
5.66%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 8 Foreign Institutions (0.06%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Novozymes A/S"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 59.75% vs 1.97% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -24.95% vs -17.55% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "28,593.20",
          "val2": "17,899.00",
          "chgp": "59.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8,797.60",
          "val2": "5,856.00",
          "chgp": "50.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "653.40",
          "val2": "223.00",
          "chgp": "193.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,283.70",
          "val2": "-488.00",
          "chgp": "-163.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,280.90",
          "val2": "3,039.00",
          "chgp": "-24.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "165.70%",
          "val2": "249.60%",
          "chgp": "-8.39%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
28,593.20
17,899.00
59.75%
Operating Profit (PBDIT) excl Other Income
8,797.60
5,856.00
50.23%
Interest
653.40
223.00
193.00%
Exceptional Items
-1,283.70
-488.00
-163.05%
Consolidate Net Profit
2,280.90
3,039.00
-24.95%
Operating Profit Margin (Excl OI)
165.70%
249.60%
-8.39%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 59.75% vs 1.97% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -24.95% vs -17.55% in Dec 2023

stock-summaryCompany CV
About Novozymes A/S stock-summary
stock-summary
Novozymes A/S
Specialty Chemicals
Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Adisseo, Beta Renewables, DONG Energy and Monsanto, and is a parent company of Novozymes Belgium BVBA, Novozymes BioAg Limited, Novozymes Canada Limited, Albumedix A/S and Organobalance GmbH, among others.
Company Coordinates stock-summary
Company Details
Krogshoejvej 36 , BAGSVAERD None : 2880
stock-summary
Tel: 45 44 46000045 3077 8682
stock-summary
Registrar Details